Benchmark Holdings plc
("Benchmark", the "Company" or the "Group")
Capital Markets Day
Benchmark Holdings, the aquaculture biotechnology and food chain sustainability business, announces that it will be holding its first Capital Markets Day for analysts and institutional investors today in London at 1 PM.
No new material information will be disclosed, and all presentation materials will be made available on the Company's website (www.benchmarkplc.com) shortly after the event.
-Ends-
|
|
Notes to Editors:
Founded in 2000, Benchmark challenges the status quo in aquaculture, agriculture and animal healthcare.
The company has proven distribution capabilities in high growth markets and through these it provides world leading: Products - through an integrated package of high genetic merit breeding stock, next era vaccines, pharmaceuticals and biocides and advanced nutrition diets for the early stages of production; Manufacturing - delivering cutting-edge technologies in animal health vaccines, aquaculture breeding production facilities /technology and state-of-the-art advanced nutrition product manufacturing; Services - from veterinary clinical and diagnostic to technical in field/on farm support and genetic programme management; Knowledge - through consultancy, professional training, technical online & book publishing and data management systems; Research - into major health and management challenges facing aquaculture, agriculture and animal health care informing the development of the group's medicines, vaccines and management technologies.
Benchmark operates internationally with offices in England, Scotland, Belgium, Ireland, Norway, Iceland, USA, Brazil, China, Russia, Portugal, Thailand and Chile. As at 30 September 2016, Benchmark employed 891 people.
For further information on Benchmark please visit www.benchmarkplc.com